Waldron Private Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-718
Closed -$212K 352
2026
Q1
$212K Buy
+718
New +$213K 0.01% 327
2025
Q1
Sell
-2,362
Closed -$549K 321
2024
Q4
$549K Buy
2,362
+47
+2% +$10.8K 0.02% 243
2024
Q3
$511K Buy
2,315
+15
+0.7% +$3.1K 0.02% 243
2024
Q2
$452K Sell
2,300
-32
-1% -$6.61K 0.02% 245
2024
Q1
$502K Sell
2,332
-282
-11% -$59.2K 0.02% 241
2023
Q4
$565K Sell
2,614
-70
-3% -$14.9K 0.03% 215
2023
Q3
$537K Buy
2,684
+92
+4% +$18.3K 0.03% 218
2023
Q2
$480K Sell
2,592
-147
-5% -$27.2K 0.02% 236
2023
Q1
$525K Sell
2,739
-110
-4% -$19.9K 0.03% 244
2022
Q4
$504K Hold
2,849
0.03% 237
2022
Q3
$504K Buy
2,849
+1,126
+65% +$223K 0.03% 237
2022
Q2
$352K Buy
1,723
+68
+4% +$14.4K 0.02% 282
2022
Q1
$393K Buy
1,655
+25
+2% +$5.87K 0.02% 278
2021
Q4
$377K Buy
1,630
+261
+19% +$57.4K 0.02% 282
2021
Q3
$264K Buy
+1,369
New +$277K 0.02% 306
2014
Q2
Sell
-3,380
Closed -$250K 123
2014
Q1
$250K Buy
+3,380
New +$255K 0.12% 89

Other funds holding CME

Waldron Private Wealth's CME Position: Q2 2026 in Review

Waldron Private Wealth sold out of CME Group (CME) in Q2 2026, closing a stake of 718 shares — an estimated $212K sold.

Waldron Private Wealth first reported a position in CME in Q1 2014 and held it in 16 quarters. The position peaked at $565K in Q4 2023. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Waldron Private Wealth reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Waldron Private Wealth sold 718 CME Group shares in Q2 2026, an estimated $212K.
  • Waldron Private Wealth first reported a position in CME Group in Q1 2014 and held it in 16 quarters.
  • Waldron Private Wealth's CME Group position peaked at $565K in Q4 2023.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.